Increased sphingoid base-1-phosphates and failure of neural tube closure after exposure to fumonisin or FTY720

被引:37
作者
Gelineau-van Waes, Janee [1 ]
Rainey, Mark A. [1 ]
Maddox, Joyce R. [1 ]
Voss, Kenneth A. [2 ]
Sachs, Andrew J. [1 ]
Gardner, Nicole M. [1 ]
Wilberding, Justin D. [3 ]
Riley, Ronald T. [2 ]
机构
[1] Creighton Univ, Sch Med, Dept Pharmacol, Omaha, NE 68178 USA
[2] USDA ARS, Toxicol & Mycotoxin Res Unit, RB Russell Res Ctr, Athens, GA 30613 USA
[3] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE USA
基金
美国国家卫生研究院;
关键词
fumonisin; FTY720; neural tube defect; exencephaly; sphingolipid; ceramide synthase; mycotoxin; sphinganine-1-phosphate; S1P receptors; neural progenitor cells; SPHINGOSINE-1-PHOSPHATE RECEPTORS; NERVOUS-SYSTEM; NULL ALLELE; 1-PHOSPHATE RECEPTORS; BICISTRONIC STRUCTURE; CERAMIDE SYNTHASES; MASS-SPECTROMETRY; CELL-MIGRATION; BIRTH-DEFECTS; SPINA-BIFIDA;
D O I
10.1002/bdra.23074
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
BACKGROUND: Fumonisin B1 (FB1) is a mycotoxin produced by a common fungal contaminant of corn. Ingestion of FB1-contaminated food is associated with increased risk for neural tube defects (NTDs). FB1 induces NTDs in inbred LM/Bc mice. FB1 inhibits ceramide synthase in de novo sphingolipid biosynthesis, resulting in accumulation of sphinganine and sphinganine-1-phosphate (Sa1P). Sa1P functions as a ligand for a family of G protein-coupled S1P receptors. METHODS: Pregnant SWV and LM/Bc mice were treated with FB1 (20 mg/kg/day intraperitoneally on embryonic day (ED) 7.58.5) or the known S1P receptor agonist FTY720 (10 mg/kg/day oral gavage on ED 6.58.5). LC/MS was used to detect sphingoid base-1-phosphates in maternal blood spots, plasma, and embryonic tissue. Strain-specific SWV and LM/Bc mouse embryonic fibroblasts (MEFs) and serum free mouse embryo (SFME) neural progenitor cells were treated with FB1 (40 mu M for 24 hr) and LC/MS was used to detect sphingoid base-1-phosphates. RESULTS: FTY720 induced NTDs in both the SWV and the LM/Bc strains of mice. Sphinganine-1-P (Sa1P) and FTY720-P were elevated in the blood spots and plasma of mice treated with FB1 or FTY720, respectively. FTY720-P was elevated in ED 9.5 exencephalic embryos. Sa1P was elevated in SFME and MEF cells treated with FB1, and Sa1P was higher in MEFs generated from the FB1-NTDsusceptible LM/Bc strain. CONCLUSIONS: Elevated sphingoid base-1-P after FB1 or FTY720 suggest a potential role for these bioactive lipid ligands and activation of S1P receptor signaling pathways in the failure of neural tube closure after FB1 or FTY720. Sa1P may represent a biomarker for FB1-NTD risk assessment. Birth Defects Research (Part A), 2012. (C) 2012 Wiley Periodicals, Inc.
引用
收藏
页码:790 / 803
页数:14
相关论文
共 85 条
[1]   Generation and characterization of a Gdf1 conditional null allele [J].
Bengtsson, Henrik ;
Epifantseva, Irina ;
Abrink, Magnus ;
Kylberg, Annika ;
Kullander, Klas ;
Ebendal, Ted ;
Usoskin, Dmitry .
GENESIS, 2008, 46 (07) :368-372
[2]   Simultaneous quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry [J].
Bielawski, Jacek ;
Szulc, Zdzislaw M. ;
Hannun, Yusuf A. ;
Bielawska, Alicja .
METHODS, 2006, 39 (02) :82-91
[3]   Trends in the postfortification prevalence of spina bifida and anencephaly in the United States [J].
Boulet, Sheree L. ;
Yang, Quanhe ;
Mai, Cara ;
Kirby, Russell S. ;
Collins, Julianne S. ;
Robbins, James M. ;
Meyer, Robert ;
Canfield, Mark A. ;
Mulinare, Joe .
BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2008, 82 (07) :527-532
[4]   The immune modulator FTY720 targets sphingosine 1-phosphate receptors [J].
Brinkmann, V ;
Davis, MD ;
Heise, CE ;
Albert, R ;
Cottens, S ;
Hof, R ;
Bruns, C ;
Prieschl, E ;
Baumruker, T ;
Hiestand, P ;
Foster, CA ;
Zollinger, M ;
Lynch, KR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (24) :21453-21457
[5]   Sphingosine 1-phosphate receptors in health and disease: Mechanistic insights from gene deletion studies and reverse pharmacology [J].
Brinkmann, Volker .
PHARMACOLOGY & THERAPEUTICS, 2007, 115 (01) :84-105
[6]   Distinct generation, pharmacology, and distribution of sphingosine 1-phosphate and dihydrosphingosine 1-phosphate in human neural progenitor cells [J].
Callihan, Phillip ;
Zitomer, Nicholas C. ;
Stoeling, Michael V. ;
Kennedy, Perry C. ;
Lynch, Kevin R. ;
Riley, Ronald T. ;
Hooks, Shelley B. .
NEUROPHARMACOLOGY, 2012, 62 (02) :988-996
[7]   Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs [J].
Cyster, JG .
ANNUAL REVIEW OF IMMUNOLOGY, 2005, 23 :127-159
[8]   Brain sphingosine-1-phosphate receptors: Implication for FTY720 in the treatment of multiple sclerosis [J].
Dev, Kumlesh K. ;
Mullershausen, Florian ;
Mattes, Henri ;
Kuhn, Rainer R. ;
Bilbe, Graeme ;
Hoyer, Daniel ;
Mir, Anis .
PHARMACOLOGY & THERAPEUTICS, 2008, 117 (01) :77-93
[9]   FTY720: Early clinical experience [J].
Dragun, D ;
Fritsche, L ;
Boehler, T ;
Peters, H ;
Budde, K ;
Neumayer, HH .
TRANSPLANTATION PROCEEDINGS, 2004, 36 (02) :544S-548S
[10]   Generation of a conditional Ppap2b/Lpp3 null allele [J].
Escalante-Alcalde, Diana ;
Sanchez-Sanchez, Roberto ;
Stewart, Colin L. .
GENESIS, 2007, 45 (07) :465-469